Chhattisgarh Medical Services Corp blacklists 4 pharma firms

  • News
  • April 30, 2016

Raipur
Chhattisgarh Medical Services Corporation black-listed four renowned medicine manufacturing companies, accused of supplying poor quality drugs. The ban has been imposed for three years on each of them. It is also planning to approach court for permanent ban on these companies, which allegedly tried to cheat state government by hiding details (these companies have been banned by other states) and also tried to sell medicine with wrong expiry dates.Brooks Laboratories Limited and Unijules Life Sciences Limited, both from Maharashtra have been banned. Another pharma company named Cardiac Healthcare Limited from Gujarat has also banned in Chhattisgarh from 2016 to 2019.
Even officials of the corporation have been accused of mismanagement, for showing callousness in verifying the documents produced by the firms.
The mismanagement was revealed after an inquiry was ordered following complaints by some doctors.
An official from the corporation informed that notices were issued to all three companies to come-up with their justifications but none of them replied to the notices. Fed-up with the prevailing black marketing being done by pharma companies in Chhattisgarh, state government has sought suggestions of common people on how the medicines should be purchased and how transparency can be maintained. On the orders of health ministry, the corporation has uploaded a format for suggestions on their website on which common people can send their views till April 23.

Related Posts

13 Years after Oxytocin Order, HC Seeks Compilance Status

GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

Centre Pushes Haryana to Fast-Track AIIMS Rewari

New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?